Additionally, PLHIV comprised a higher proportion in primary MDR-TB cases, 24 (56%), than in previously treated cases, 68 (38%) (P=.03), although CD4 counts did not vary between those groups (Table 2). This evidence concerns the gene CD4 and multidrug-resistant tuberculosis.